Céline Verstuyft

8PUBLICATIONS
59CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersGene and molecular therapyTe ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Cellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 19, 2026
Effects of prucalopride on anxiety and depressive symptoms among constipated patients: A meta-analysis of randomized controlled trials.

|Sep 11, 2026
Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses.

|Nov 25, 2024
French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten.

Louis Lebreton, Jean-Christophe Boyer, Claire Lafay-Chebassier

|Jun 24, 2024
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics.

Xenia Marlene Hart, Gerhard Gründer, Nicolas Ansermot

|Apr 28, 2023
Major Depressive Disorder and Oxidative Stress: A Review of Peripheral and Genetic Biomarkers According to Clinical Characteristics and Disease Stages.

Abd El Kader Ait Tayeb, Vianney Poinsignon, Kenneth Chappell

|Jan 08, 2023
The MAOA rs979605 Genetic Polymorphism Is Differentially Associated with Clinical Improvement Following Antidepressant Treatment between Male and Female Depressed Patients.

Kenneth Chappell, Romain Colle, Jérôme Bouligand

Pageof 2

Frequent Collaborators

3 joint publications

Laurent Becquemont

3 joint publications

Abd El Kader Ait Tayeb

2 joint publications

Matthieu Gasnier

2 joint publications

Elodie Gautier-Veyret